• ITVI.USA
    15,442.580
    19.940
    0.1%
  • OTLT.USA
    2.891
    0.002
    0.1%
  • OTRI.USA
    20.850
    -0.110
    -0.5%
  • OTVI.USA
    15,411.420
    23.220
    0.2%
  • TSTOPVRPM.ATLPHL
    2.920
    -0.040
    -1.4%
  • TSTOPVRPM.CHIATL
    3.680
    -0.030
    -0.8%
  • TSTOPVRPM.DALLAX
    1.290
    -0.060
    -4.4%
  • TSTOPVRPM.LAXDAL
    3.620
    -0.020
    -0.5%
  • TSTOPVRPM.PHLCHI
    2.420
    0.100
    4.3%
  • TSTOPVRPM.LAXSEA
    4.170
    0.000
    0%
  • WAIT.USA
    128.000
    2.000
    1.6%
  • ITVI.USA
    15,442.580
    19.940
    0.1%
  • OTLT.USA
    2.891
    0.002
    0.1%
  • OTRI.USA
    20.850
    -0.110
    -0.5%
  • OTVI.USA
    15,411.420
    23.220
    0.2%
  • TSTOPVRPM.ATLPHL
    2.920
    -0.040
    -1.4%
  • TSTOPVRPM.CHIATL
    3.680
    -0.030
    -0.8%
  • TSTOPVRPM.DALLAX
    1.290
    -0.060
    -4.4%
  • TSTOPVRPM.LAXDAL
    3.620
    -0.020
    -0.5%
  • TSTOPVRPM.PHLCHI
    2.420
    0.100
    4.3%
  • TSTOPVRPM.LAXSEA
    4.170
    0.000
    0%
  • WAIT.USA
    128.000
    2.000
    1.6%
American ShipperLogisticsNewsSupply Chains

COVID-19 vaccine distribution could start in mid-December, official says

Distribution of the first COVID-19 vaccines in the U.S. could begin as early as Dec. 11, the lead adviser for Operation Warp Speed said on Sunday.

“Our plan is to be able to ship vaccines to the immunization sites within 24 hours from the approval, so I would expect maybe on day two after approval, on the 11th or on the 12th of December,” Dr. Moncef Slaoui said during an interview on CNN.

Slaoui’s comments came after Pfizer submitted an application to the Food and Drug Administration for emergency authorization to approve its candidate vaccine. An application from Moderna for its vaccine candidate is expected soon.

Operation Warp Speed, the U.S. government’s coronavirus vaccine program, has been ramping up preparations to distribute doses across the country. On Wednesday, officials said they expect about 40 million doses of vaccines could be available by the end of December. 

Pfizer’s and Moderna’s vaccine candidates have so far emerged as the most promising ones in development, with preliminary data showing efficacy rates around 95%.

The companies have already manufactured and stockpiled doses in anticipation of the rollout. 

Click for more FreightWaves articles by Nate Tabak
Rookie trucker held after CBP finds pot in Texas-bound pork shipment
Canada clears 5 firms to bid on COVID-19 vaccine distribution contract
When ransomware attacks hit, companies choose between pay and pain

Nate Tabak, Border and North America Correspondent

Nate Tabak is a Toronto-based journalist and producer who covers cybersecurity and cross-border trucking and logistics for FreightWaves. He spent seven years reporting stories in the Balkans and Eastern Europe as a reporter, producer and editor based in Kosovo. He previously worked at newspapers in the San Francisco Bay Area, including the San Jose Mercury News. He graduated from UC Berkeley, where he studied the history of American policing. Contact Nate at ntabak@freightwaves.com.

We are glad you’re enjoying the content

Sign up for a free FreightWaves account today for unlimited access to all of our latest content

By signing in for the first time, I give consent for FreightWaves to send me event updates and news. I can unsubscribe from these emails at any time. For more information please see our Privacy Policy.